BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33172206)

  • 1. Antibiofilm Activity on
    Aguiar FLL; Santos NC; de Paula Cavalcante CS; Andreu D; Baptista GR; Gonçalves S
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
    de Aguiar FLL; Cavalcante CSDP; Dos Santos Fontenelle RO; Falcão CB; Andreu D; Rádis-Baptista G
    J Appl Microbiol; 2020 Feb; 128(2):414-425. PubMed ID: 31626724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin.
    Cavalcante CS; Falcão CB; Fontenelle RO; Andreu D; Rádis-Baptista G
    J Antibiot (Tokyo); 2017 Mar; 70(3):231-237. PubMed ID: 27876749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
    do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I
    Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans.
    Jafri H; Khan MSA; Ahmad I
    Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the candidacidal mechanism of Ctn[15-34] - a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins.
    Cavalcante CSP; de Aguiar FLL; Fontenelle ROS; de Menezes RRPPB; Martins AMC; Falcão CB; Andreu D; Rádis-Baptista G
    J Med Microbiol; 2018 Jan; 67(1):129-138. PubMed ID: 29214974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action.
    Maione A; Bellavita R; de Alteriis E; Galdiero S; Albarano L; La Pietra A; Guida M; Parrilli E; D'Angelo C; Galdiero E; Falanga A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216270
    [No Abstract]   [Full Text] [Related]  

  • 9. Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
    Curvelo JAR; Moraes DC; Anjos CAD; Portela MB; Soares RMA
    An Acad Bras Cienc; 2019; 91(1):e20180045. PubMed ID: 30994755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom.
    Pérez-Peinado C; Dias SA; Domingues MM; Benfield AH; Freire JM; Rádis-Baptista G; Gaspar D; Castanho MARB; Craik DJ; Henriques ST; Veiga AS; Andreu D
    J Biol Chem; 2018 Feb; 293(5):1536-1549. PubMed ID: 29255091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Susceptibility of Drug-Resistant
    Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology.
    Falcao CB; Radis-Baptista G
    Peptides; 2020 Apr; 126():170234. PubMed ID: 31857106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rhodamine B-encrypted Vipericidin Peptide, RhoB-Ctn[1-9], Displays In vitro Antimicrobial Activity Against Opportunistic Bacteria and Yeasts.
    Lima HVD; Dos Santos TMC; de Sousa Silva MMA; da Silva Albuquerque JV; Melo LM; de Figueirêdo Freitas VJ; Rádis-Baptista G
    Curr Pharm Biotechnol; 2022; 23(2):172-179. PubMed ID: 33749557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Xia J; Qian F; Xu W; Zhang Z; Wei X
    Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
    Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS
    Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-1,3-glucanase disrupts biofilm formation and increases antifungal susceptibility of Candida albicans DAY185.
    Tan Y; Ma S; Leonhard M; Moser D; Schneider-Stickler B
    Int J Biol Macromol; 2018 Mar; 108():942-946. PubMed ID: 29104052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625.
    Galdiero E; de Alteriis E; De Natale A; D'Alterio A; Siciliano A; Guida M; Lombardi L; Falanga A; Galdiero S
    Sci Rep; 2020 Apr; 10(1):5780. PubMed ID: 32238858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.
    Alves F; de Oliveira Mima EG; Passador RCP; Bagnato VS; Jorge JH; Pavarina AC
    Lasers Med Sci; 2017 May; 32(4):815-826. PubMed ID: 28280998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
    Mora-Navarro C; Caraballo-León J; Torres-Lugo M; Ortiz-Bermúdez P
    J Pept Sci; 2015 Dec; 21(12):853-61. PubMed ID: 26470850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.
    Madariaga-Venegas F; Fernández-Soto R; Duarte LF; Suarez N; Delgadillo D; Jara JA; Fernández-Ramires R; Urzúa B; Molina-Berríos A
    PLoS One; 2017; 12(5):e0176755. PubMed ID: 28493889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.